Two Sigma Investments, LP X4 Pharmaceuticals, Inc Transaction History

Two Sigma Investments, LP

  • $42.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$0.82 - $2.49 $374,320 - $1.14 Million
456,489 Added 2845.23%
472,533 $916,000
Q1 2023

May 15, 2023
SELL
$0.8 - $1.22 $4,846 - $7,390
-6,058 Reduced 27.41%
16,044 $13,000
Q4 2022

Feb 14, 2023
BUY
$0.69 - $2.21 $15,250 - $48,845
22,102 New
22,102 $21,000

Others Institutions Holding XFOR

# of Institutions
104
Shares Held
100M
Call Options Held
213K
Put Options Held
50.6K
View Full List

About X4 Pharmaceuticals, Inc

XFOR Quotes by TradingView
  • Ticker XFOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,646,096
  • Market Cap $48.1M
  • Description
  • X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...
More about XFOR
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email